| Literature DB >> 21432942 |
Samuel J Aronson1, Eugene H Clark, Lawrence J Babb, Samantha Baxter, Lisa M Farwell, Birgit H Funke, Amy Lovelette Hernandez, Victoria A Joshi, Elaine Lyon, Andrew R Parthum, Franklin J Russell, Matthew Varugheese, Thomas C Venman, Heidi L Rehm.
Abstract
The future of personalized medicine will hinge on effective management of patient genetic profiles. Molecular diagnostic testing laboratories need to track knowledge surrounding an increasingly large number of genetic variants, incorporate this knowledge into interpretative reports, and keep ordering clinicians up to date as this knowledge evolves. Treating clinicians need to track which variants have been identified in each of their patients along with the significance of these variants. The GeneInsight(SM) Suite assists in these areas. The suite also provides a basis for interconnecting laboratories and clinicians in a manner that increases the scalability of personalized medicine processes.Entities:
Mesh:
Year: 2011 PMID: 21432942 PMCID: PMC3082613 DOI: 10.1002/humu.21470
Source DB: PubMed Journal: Hum Mutat ISSN: 1059-7794 Impact factor: 4.878